Global and national HIV/AIDS policies utilize the care cascade to emphasize the importance of continued engagement in HIV services from diagnosis to viral suppression. Several studies have documented barriers that men experience in accessing services at specific stages of care, but few have analyzed how these barriers operate along the care cascade. Brazil offers a unique setting for analyzing barriers to HIV care because it is a middleincome country with a large HIV epidemic and free, universal access to HIV/AIDS services. Semi-structured interviews were conducted in 2011 with HIV-infected men (n = 25) receiving care at the only HIV/AIDS state reference center in Salvador, Brazil, the third largest city in the country. Interviews were transcribed and coded for analysis. Researchers identified barriers to services along the care cascade: health service-related obstacles (poorquality care, lengthy wait times, and drug supply problems); psychosocial and emotional challenges (fear of disclosure and difficulty accepting HIV diagnosis); indirect costs (transportation and absenteeism at work or school); low perceived risk of HIV; and toxicity and complexity of antiretroviral drug (ARV) regimens. The stages of the care cascade interrupted by each barrier were also identified. Most barriers affected multiple, and often all, stages of care, while toxicity and complexity of ARV regimens was only present at a single care stage. Efforts to eliminate more prevalent barriers have the potential to improve care continuity at multiple stages. Going forward, assessing the relative impact of barriers along one's entire care trajectory can help tailor improvements in service provision, facilitate achievement of viral suppression, and improve access to life-saving testing, treatment, and care.
Introduction
Viral suppression minimizes HIV-related morbidity and mortality and reduces HIV transmission (Cohen et al., 2011; Gardner, McLees, Steiner, Del Rio, & Burman, 2011) . Antiretroviral drugs (ARVs) can effectively suppress viral loads, but late diagnosis, delayed linkage to care, and interruptions in adherence can compromise viral suppression, promote HIV progression, and facilitate ARV resistance (Anglaret et al., 2012; Harrigan et al., 2005; Hogan et al., 2012) . As such, research has attempted to understand and improve linkages between stages of HIV care that collectively make up the HIV care cascade. The care cascade defined by the U.S. Centers for Disease Control and Prevention includes: HIV diagnosis, linkage to care, retention in care, ARV provision, and viral suppression (HIV/AIDS Care Continuum, 2013) .
Brazil, one of the first countries to guarantee free, universal ARV provision, has utilized the care cascade to assess national engagement in care. An estimated 80% of HIV-infected individuals know their HIV status, but only 33% maintain undetectable viral loads (Boletim Epidemiológico: HIV/AIDS, 2013). Notably, in 2012, men comprised 65% of AIDS cases, and HIV-infected men experienced nearly double the mortality rate of women (Boletim Epidemiológico: HIV/AIDS, 2013). While factors such as male gender, older age, and substance use have been associated with delays at specific care stages (de Almeida et al., 2014; Grangeiro, Escuder, & Pereira, 2012; Guimaraes et al., 2008) , few studies have analyzed how barriers impede access to services along the entire care cascade, particularly in resource-limited settings (Mukolo, Villegas, Aliyu, & Wallston, 2013) . Therefore, to improve the quality of HIV services, we explored barriers affecting HIV-infected men at each stage of care in Salvador, Brazil.
Methods
Semi-structured interviews were conducted with 25 HIV-infected men in Salvador, Brazil's third largestand one of its lowest-incomecities. Through convenience sampling, members of the research team invited patients of a previous quantitative survey to participate in an interview at the time of a scheduled medical consultation or pharmacy visit at Salvador's only State Reference Center in 2011. For the quantitative survey, a list of scheduled patients at the State Reference Center had been provided to the study team, and staff members invited all patients to participate. To be included in the study, participants must have been 18 or older and have had a laboratory confirmed HIV diagnosis. Participants were excluded if they had received initial HIV/AIDS care at another health facility or were diagnosed with mental health disorders. Interview scripts were extensively fieldtested and included open-ended questions about participants' care trajectories, sexual behaviors, and social experiences related to HIV. Interviews were conducted individually in private rooms after obtaining informed consent. No compensation was given for participation. All interviews were recorded, transcribed, and analyzed in Portuguese.
Barriers were defined as experiences reported by men that delayed or impeded access to HIV diagnosis, linkage to care, retention in care, ARV provision, or continued treatment to achieve viral suppression. Two authors (L.A.S., I.D.) identified initial themes to code data through a literature review and deductively coded transcripts using NVivo software (QSR International; Crabtree & Miller, 1999) . Researchers (M.H., S.M., and A.B.) identified barriers reported in transcripts and inductively coded themes emerging outside the literature (Boyatzis, 1998) . During this process, common categories of barriers emerged. Outliers were explored by analyzing responses according to employment status, drug use, and sexual behavior to determine whether these sociodemographic characteristics were tied to any identified barriers.
Results
Participant socio-demographic characteristics are summarized in Table 1 . Men reported health service-related obstacles (poor-quality care, lengthy wait times, and drug supply problems); psychosocial and emotional challenges (fear of disclosure and difficulty accepting HIV diagnosis); indirect costs (transportation and absenteeism at work or school); low perceived risk of HIV; and toxicity and complexity of ARV regimens. Most barriers interrupted multiple stages of the care cascade, while toxicity and complexity of ARV regimens was only present at a single stage.
Among service-related obstacles, dissatisfaction with care from service providers and lengthy wait times negatively affected access to every care stage, while drug supply problems obstructed ARV provision and continued treatment. Emotional and psychosocial challenges impeded engagement at every stage. Indirect costs limited retention in care and continued treatment. Low perceived risk of HIV infection and disease progression delayed diagnosis and linkage to care. Toxicity and complexity of ARV regimens interrupted continued treatment. Notably, among socio-demographic characteristics explored, barriers differed only by sexual behavior: all men who have sex with men (MSM) feared disclosure and reported common experiences with HIV-related stigma, discrimination, violence, and homophobia. Nonetheless, about half of the study's men who had sex with only women (MSW) also reported fear of disclosure and often described experiences of HIV-related stigma and discrimination.
In sum, HIV-infected men in Salvador, Brazil face many barriers that collectively impede access to care "I take [the medication] and I don't, … I've had negative reactions to the majority of the drugs … . I'm still trying to find a better combination" AIDS Care 59 at every stage. Results are further detailed in Figure 1 and example quotes are found in Table 2 .
Discussion
With respect to health service provision, poor-quality care and lengthy wait times were common reasons for disengagement in all stages of HIV care. Prior studies in Brazil and other high-and low-income settings found that similar service-related obstacles discouraged HIV testing, exacerbated loss to follow-up, and increased likelihood of non-adherence (de Almeida et al., 2014; Bezabhe et al., 2014; Bonolo et al., 2005; Lorenc et al., 2011; Meyerson et al., 2014; Schuster et al., 2005) . Measures to improve patient satisfaction and diminish wait times are necessary steps to enhancing care continuity. Potential strategies include training healthcare workers to address specific complaints that emerged from the interviews, including confidentiality and provider-patient interactions; adequately matching demand for care with provider availability; and improving organizational procedures to expedite care. While participant descriptions of poor-quality care and wait times are consistent with current literature, the availability of ARVs in Brazil is disputed. Reports of a limited drug supply are concerning given Brazil's guarantee of ARVs and adoption of a test-and-treat strategy (Protocolo Clínico e Diretrizes Terapêuticas para Manejo da Infecção pelo HIV em Adultos, 2013). While some studies have reported drug shortages (Melchior et al., 2006; Ribeiro, Tupinambas, Fonseca, & Greco 2012) , a national survey of providers described sufficient ARV stock (Nemes et al., 2013) . Given these discrepancies, future research should investigate HIV drug supply in Brazil and its impact on patient care.
Emotional and psychosocial challenges, including fear of disclosure and difficulty accepting an HIV diagnosis, limited access to all care stages. These results are consistent with prior research (Kerr et al., 2013; Melchior, Nemes, Alencar, & Buchalla, 2007; Nakigozi et al., 2013; Nelson et al., 2010; Solorio, Forehand, & Simoni, 2013; Souza Vde and Czeresnia, 2013) . Improved availability and quality of counseling services may help HIV-infected men accept HIV diagnosis and negotiate disclosure. Notably, services must consider privacy, as many participants emphasized concerns about confidentiality at the Reference Center. While several studies have highlighted positive effects of counseling services on continuity of care (Gruber et al., 2011; Leider, Fettig, & Calderon, 2011) , these services must be tailored to needs of their community. Notably, all MSM feared disclosure and reported common experiences with HIV-related stigma, discrimination, violence, and homophobia. While Brazil responded progressively to diverse sexualities early in the epidemic, social conservatism has presented new challenges to the country's stance on homosexuality (Corrêa, 2013) . Given that MSW also reported fear of disclosure, in addition to MSM's disproportionate representation in Brazil's epidemic (Kerr et al., 2013; Malta et al., 2010) , efforts to eliminate HIV-related stigma, discrimination, violence, and homophobia should be redoubled.
Indirect costs associated with transportation and absenteeism at work or school impeded access to retention in care and continued treatment, and these are well-known predictors of poor health outcomes across stages of care in Salvador and elsewhere (Eberhart et al., 2013; Ferreira & da Silva, 2012; Lankowski, Siedner, Bangsberg, & Tsai, 2014; Oliveira, 2009; Saha et al., 2014; Trepka et al., 2014) . Even in settings where ARVs are free, indirect costs must be addressed to increase care continuity. Transportation vouchers and expanded consultation and pharmacy hours could mitigate these challenges.
Low perceived risk of HIV was a barrier to both HIV diagnosis and linkage to care. While prior studies indicate that men frequently do not perceive themselves at risk for HIV (Filipe et al., 2005; Kerr et al., 2013; Souza Vde and Czeresnia, 2013) , our study connects low perceived risk with later HIV diagnosis and disrupted care. Increased routine testing can facilitate earlier diagnosis by informing individuals of their status regardless of risk perception. Service providers must also ensure newly diagnosed individuals understand consequences of disease progression and interrupted care. Continued research is needed to identify and address factors that delay HIV diagnosis, as many participants underwent testing only upon diagnosis of another medical problem.
Prior research in Brazil and elsewhere links ARV toxicity and complexity with interrupted treatment (Bezabhe et al., 2014; Guimaraes et al., 2008; Melchior et al., 2007; Saha et al., 2014) . While HIV is increasingly understood as a chronic disease, continued support for the emotional and physical impact of taking ARVs is needed. Increased access to simplified regimens and combination drugs throughout Brazil may improve adherence and facilitate viral suppression.
This study's primary limitation is that all participants were connected to care, excluding those most disenfranchised. Further, this analysis did not assess clinical status, and the small sample size limited generalizability of findings. Additionally, models of the care cascade are not well defined in national or global guidelines, so assigning barriers to stages is not always straightforward. Nonetheless, this study uniquely assesses barriers to HIV care by contextualizing them along the entire care cascade.
Conclusion
This analysis demonstrates that efforts to eliminate more prevalent barriers along the care cascade may improve continued engagement in services by operating at multiple care stages. Research should further explore the relative impact of barriers along one's entire care trajectory, including those limiting HIV diagnosis and affecting vulnerable populations. Diminishing barriers along the care cascade can reduce HIV-related morbidity and mortality in Brazil, and globally, by improving access to life-saving testing, treatment, and care.
